Overview: Gastrointestinal manifestations and management

Seth Sweetser; Michael Camilleri

doi:10.1007/978-1-4419-5774-0_39

Overview: Gastrointestinal manifestations and management

Seth Sweetser, Michael Camilleri

Gastroenterology and Hepatology

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Systemic sclerosis (SSc, scleroderma) is a chronic, connective tissue disease characterized by vascular damage and fibrosis of the skin and internal organs including the gastrointestinal (GI) tract. After skin involvement, the GI tract is the second most commonly involved organ system with the esophagus being the most frequent segment involved. Involvement of the stomach, small intestine, colon, and anorectum is less common but may lead to severe complications and debility. Ultimately, over 80% of individuals with scleroderma will experience a change in normal GI function [1, 2].

Original language	English (US)
Title of host publication	Scleroderma
Subtitle of host publication	From Pathogenesis to Comprehensive Management
Publisher	Springer US
Pages	463-469
Number of pages	7
ISBN (Electronic)	9781441957740
ISBN (Print)	9781441957733
DOIs	https://doi.org/10.1007/978-1-4419-5774-0_39
State	Published - Jan 1 2012

Keywords

Gastrointestinal management
Gastrointestinal manifestations
Overview
Pathogenesis
Pathology
Prevalence of gastrointestinal symptoms
Stomach involvement

ASJC Scopus subject areas

General Medicine

Access to Document

10.1007/978-1-4419-5774-0_39

Cite this

@inbook{6ce5947f33204779a5b8cb0348f8ac18,

title = "Overview: Gastrointestinal manifestations and management",

abstract = "Systemic sclerosis (SSc, scleroderma) is a chronic, connective tissue disease characterized by vascular damage and fibrosis of the skin and internal organs including the gastrointestinal (GI) tract. After skin involvement, the GI tract is the second most commonly involved organ system with the esophagus being the most frequent segment involved. Involvement of the stomach, small intestine, colon, and anorectum is less common but may lead to severe complications and debility. Ultimately, over 80% of individuals with scleroderma will experience a change in normal GI function [1, 2].",

keywords = "Gastrointestinal management, Gastrointestinal manifestations, Overview, Pathogenesis, Pathology, Prevalence of gastrointestinal symptoms, Stomach involvement",

author = "Seth Sweetser and Michael Camilleri",

year = "2012",

month = jan,

day = "1",

doi = "10.1007/978-1-4419-5774-0_39",

language = "English (US)",

isbn = "9781441957733",

pages = "463--469",

booktitle = "Scleroderma",

publisher = "Springer US",

}

TY - CHAP

T1 - Overview

T2 - Gastrointestinal manifestations and management

AU - Sweetser, Seth

AU - Camilleri, Michael

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Systemic sclerosis (SSc, scleroderma) is a chronic, connective tissue disease characterized by vascular damage and fibrosis of the skin and internal organs including the gastrointestinal (GI) tract. After skin involvement, the GI tract is the second most commonly involved organ system with the esophagus being the most frequent segment involved. Involvement of the stomach, small intestine, colon, and anorectum is less common but may lead to severe complications and debility. Ultimately, over 80% of individuals with scleroderma will experience a change in normal GI function [1, 2].

AB - Systemic sclerosis (SSc, scleroderma) is a chronic, connective tissue disease characterized by vascular damage and fibrosis of the skin and internal organs including the gastrointestinal (GI) tract. After skin involvement, the GI tract is the second most commonly involved organ system with the esophagus being the most frequent segment involved. Involvement of the stomach, small intestine, colon, and anorectum is less common but may lead to severe complications and debility. Ultimately, over 80% of individuals with scleroderma will experience a change in normal GI function [1, 2].

KW - Gastrointestinal management

KW - Gastrointestinal manifestations

KW - Overview

KW - Pathogenesis

KW - Pathology

KW - Prevalence of gastrointestinal symptoms

KW - Stomach involvement

UR - http://www.scopus.com/inward/record.url?scp=85026488485&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026488485&partnerID=8YFLogxK

U2 - 10.1007/978-1-4419-5774-0_39

DO - 10.1007/978-1-4419-5774-0_39

M3 - Chapter

AN - SCOPUS:85026488485

SN - 9781441957733

SP - 463

EP - 469

BT - Scleroderma

PB - Springer US

ER -

Overview: Gastrointestinal manifestations and management

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this